Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
Abstract While vaccination against HIV-1 has been so far unsuccessful, recently broadly neutralizing antibodies (bNAbs) against HIV-1 envelope glycoprotein were shown to induce long-term suppression in the absence of antiretroviral therapy in patients with antibody-sensitive viral reservoirs. The re...
Saved in:
| Main Authors: | Jord C. Stam, Steven de Maat, Dorien de Jong, Mathia Arens, Fenna van Lint, Lavina Gharu, Mark H. van Roosmalen, Rob C. Roovers, Nika M. Strokappe, Ralf Wagner, Alexander Kliche, Hans J. de Haard, Paul M. van Bergen en Henegouwen, Monique Nijhuis, C. Theo Verrips |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-022-15993-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
by: Jord C. Stam, et al.
Published: (2025-04-01) -
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
by: Nika Strokappe, et al.
Published: (2012-01-01) -
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody
by: Sabrina Oliveira, et al.
Published: (2012-01-01) -
Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.
by: Laura E McCoy, et al.
Published: (2014-12-01) -
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.
by: Anna Hultberg, et al.
Published: (2011-04-01)